British Association of Dermatologists biologics register update

A web-based UK register of biological and conventional therapy for psoriasis was set up in September 2007 by the British Association of Dermatologists

Aweb-based UK register of biological and conventional therapy for psoriasis was set up in September 2007 by the British Association of Dermatologists (BAD), with the aim of assessing the long-term safety of biologics prescribed for severe disease.

The BAD Biologic Interventions Register is a prospective observational cohort study currently involving more than 3,000 patients, with around two-thirds receiving biologics and the rest (controls), conventional therapies.

The register will run for five years and has engaged clinical dermatologists and nurses from dermatology centres. Primary study endpoints include malignancy, infection, serious adverse events and death. Collection of long-term effectiveness data is a subsidiary aim.
Burden AD, Warren RB, Kleyn CE et al. Br J Dermatol 2012; 166(3): 545-54

Want news like this straight to your inbox?
Sign up for our bulletins

Read these next

The role of biological agents in the management of psoriasis

The range of biologics for the treatment of psoriasis...

Biologics in the treatment of psoriasis

Biologics in the treatment of psoriasis

Research continues to expand the range of biologics...

Biologics for chronic plaque psoriasis

Researchers have investigated biologics for chronic...



Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in

MIMS Product Slides

Product overviews prepared by the MIMS team, in a handy slide format.

Click here

Slides are initiated, funded & reviewed by the companies specified.

MIMS Dermatology

Read the latest issue online exclusively on MIMS Learning.

Read MIMS Dermatology

MIMS app

Access the full drug database and quick-reference tables on the go

Find out more